Mounjaro (Tirzepatide) KwikPen 15 mg / 4 Doses (8 weeks supply)

Mounjaro (Tirzepatide) KwikPen 15 mg / 4 Doses Mounjaro is a modern injectable medication based on tirzepatide, designed for blood glucose control in patients with type 2 diabetes, and also used as part of weight management programs under medical supervision. The product is available in a convenient pre-filled KwikPen designed for 4 weeks of use. Composition and form: Each pen contains 4 doses of 15 mg tirzepatide (total 60 mg in 2.4 ml solution). The solution is clear, colorless or slightly yellowish, and ready to use without any preparation. Mechanism of action: Tirzepatide is an innovative dual GIP and GLP-1 receptor agonist. It helps to: reduce blood glucose levels improve insulin sensitivity decrease appetite support gradual weight loss Directions for use: Administer subcutaneously once weekly (in the abdomen, thigh, or upper arm). One pen is designed for 4 consecutive injections. Indications: Type 2 diabetes mellitus Overweight and obesity (as prescribed by a healthcare professional) Benefits: convenient once-weekly dosing effective glycemic control additional weight loss support easy self-administration Possible side effects: The most common include: nausea digestive disturbances reduced appetite fatigue These effects are usually temporary and tend to decrease as the body adjusts.